Medical practice launches revolutionary cancer detection tests

Midland Health - a renowned private medical practice based in Birmingham and Leicester - has launched revolutionary cancer detection tests at their clinics, through their partnership with Datar Cancer Genetics, a leading international provider of comprehensive cancer gene tests.

With their joint expertise, Midland Health and Datar Cancer Genetics will provide access to the ground-breaking Trucheck Intelli cancer gene test throughout local communities.

The Trucheck Intelli tests are renowned for accuracy and can detect over 70 types of cancers, enabling earlier and more targeted treatment options.

By leveraging the most advanced technologies for cancer detection and the highest quality care from Midland Health and Datar Cancer Genetics, patients can be assured of the most accurate and efficient service.

Unlike conventional screening tests, this cutting-edge solution allows for a non-invasive investigation via a simple blood draw, whilst being completely radiation-free, providing that all-important peace of mind.

Studies have shown that the Trucheck Intelli test has correctly identified cancers in participants even in early stages of cancer.

Speaking of the launch and partnership, Dr Rupa Parmar, medical director of Midland Health said: “To be able to launch the most advanced and extensive cancer gene test on the market is a true milestone for Midland Health.

“We 're delighted to partner with Datar Cancer Genetics and excited about the role the Trucheck Intelli test and Midland Health can continue to play in changing the lives of our patients for the better. ”

To find out more about the innovative technology and what types of cancers it can detect or to book a test with Midland Health, click here.